ZA947065B - Therapeutic use of the retinoblastoma susceptibility gene product - Google Patents

Therapeutic use of the retinoblastoma susceptibility gene product

Info

Publication number
ZA947065B
ZA947065B ZA947065A ZA947065A ZA947065B ZA 947065 B ZA947065 B ZA 947065B ZA 947065 A ZA947065 A ZA 947065A ZA 947065 A ZA947065 A ZA 947065A ZA 947065 B ZA947065 B ZA 947065B
Authority
ZA
South Africa
Prior art keywords
gene product
therapeutic use
susceptibility gene
retinoblastoma susceptibility
retinoblastoma
Prior art date
Application number
ZA947065A
Other languages
English (en)
Inventor
Wen-Haw Lee
Eva Y-H P Lee
H Michael Shepard
Duane Johnson
David W Goodrich
Nan Ping Wang
Original Assignee
Univ California
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Canji Inc filed Critical Univ California
Publication of ZA947065B publication Critical patent/ZA947065B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA947065A 1993-09-13 1994-09-13 Therapeutic use of the retinoblastoma susceptibility gene product ZA947065B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12110893A 1993-09-13 1993-09-13

Publications (1)

Publication Number Publication Date
ZA947065B true ZA947065B (en) 1995-05-03

Family

ID=22394606

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947065A ZA947065B (en) 1993-09-13 1994-09-13 Therapeutic use of the retinoblastoma susceptibility gene product

Country Status (4)

Country Link
AU (1) AU7834994A (xx)
IL (1) IL110954A (xx)
WO (1) WO1995007708A2 (xx)
ZA (1) ZA947065B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
JP2001502522A (ja) 1996-06-13 2001-02-27 コンセホ・スペリヨル・デ・インベステイガシヨンズ・シエンテイフイカス 網膜芽細胞腫関連植物蛋白
CA2257972A1 (en) * 1996-06-13 1997-12-18 Consejo Superior De Investigaciones Cientificas Plant proteins
ES2234040T3 (es) 1996-11-15 2005-06-16 Canji, Inc. Expresion especifica de tejido de la proteina del retinoblastoma.
CA2281899A1 (en) * 1997-02-20 1998-08-27 Board Of Regents, The University Of Texas System Modified retinoblastoma tumor suppressor proteins
WO2004094996A2 (en) * 2001-07-12 2004-11-04 Duke University System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
ATE168135T1 (de) * 1988-01-21 1998-07-15 Massachusetts Eye & Ear Infirm Diagnose von retinoblastoma
KR970005049B1 (ko) * 1990-07-16 1997-04-11 더 리젠츠 오브 더 유니벌시티 오브 캘리포니아 바쿨로비루스 발현 시스템, 이 벡터 시스템을 포함하는 이종성 무척추동물 숙주세포, 상기 시스템에 의해 생산되는 가용성의 정제된 야생형 망막아세포종 폴리펩티드 및 이 폴리펩티드의 생산 방법
WO1992022640A1 (en) * 1991-06-10 1992-12-23 Research Development Foundation Rb TRANSFERRED CELLS AND METHOD

Also Published As

Publication number Publication date
WO1995007708A3 (en) 1995-06-08
IL110954A (en) 1999-12-22
WO1995007708A2 (en) 1995-03-23
AU7834994A (en) 1995-04-03
IL110954A0 (en) 1994-11-28

Similar Documents

Publication Publication Date Title
AU3972893A (en) Gene therapy using the intestine
EP0728202A4 (en) EPISOMIC EXPRESSION VECTOR FOR HUMAN GENE THERAPY
EP0688358A4 (en) IMPROVED VECTORS FOR GENTHERAPY
ZA931632B (en) Novel arylindazoles and their use as herbicides
EP0723460A4 (en) GENE THERAPY FOR THE NERVOUS SYSTEM
ZA947065B (en) Therapeutic use of the retinoblastoma susceptibility gene product
ZA948506B (en) Pharmaceutical product
ZA913844B (en) Therapeutic product
ZA941941B (en) Use of ferrocene
GB9317752D0 (en) New pharmaceutical use
ZA93425B (en) Novel arylindoles and their use as herbicides
ZA945892B (en) Microparticles processes for their preparation and their use for the preparation of medicaments
GB9310441D0 (en) Gene therapy
EG20501A (en) Process for the agrochemical treatment of grasslands
EP0340392A3 (en) Beta-diketone-polymer reaction product and use thereof
GB9616504D0 (en) Therapeutic product and its use
GB9412405D0 (en) Chemical intermediates and the use thereof
AU121465S (en) Portable product display
ZA935474B (en) Treatment of titaniferous materials
KR0111459Y1 (en) Material of use much of the display panel
GB9209416D0 (en) Therapeutic amides
HU9200005D0 (en) Process and product
GB9616823D0 (en) Therapeutic product and its use
GB9616506D0 (en) Therapeutic product and its use
GB9616503D0 (en) Therapeutic product and its use